Inhibition of Co-Stimulation in Rheumatoid Arthritis

Phase 4 Unknown 25 enrolled NHS Greater Glasgow and Clyde University of Glasgow · collab

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to use abatacept as a clinical molecular probe to evaluate the effects of inhibiting costimulation on immune responses in patients with rheumatoid arthritis (RA).

Timeline

Start: 2016-01
Primary completion: 2019-01
Completion: 2019-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Abatacept	Other / unclassified	125 mg	Subcutaneous

Inhibition of Co-Stimulation in Rheumatoid Arthritis

Summary

Timeline

Drugs

Indications